NAFCILLIN (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the NAFCILLIN drug offered from Baxter Healthcare Corporation. This Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | NAFCILLIN |
SUBSTANCE NAME: | NAFCILLIN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1989-10-31 |
END MARKETING DATE: | 0000-00-00 |
NAFCILLIN HUMAN PRESCRIPTION DRUG Details:
Item Description | NAFCILLIN from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(g/50mL) |
START MARKETING DATE: | 1989-10-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-1017_e938575e-57ca-4ab0-964f-adcd05d78a33 |
PRODUCT NDC: | 0338-1017 |
APPLICATION NUMBER: | NDA050655 |
Other NAFCILLIN SODIUM Pharmaceutical Manufacturers / Labelers: